INA-6-CD63-EGFP cell line
Invented by Dr Gaute Brede from Norwegian University of Science and Technology (NTNU)
Invented at Norwegian University of Science and Technology (NTNU)
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 160388 |
| Antigen/Gene or Protein Targets | INA6-CD63 |
| Parental Line | INA6 |
| Host | Human |
| Tissue | Blood |
| Disease Keywords | Myeloma |
| Relevance |
This human myeloma cell line expresses CD63-EGFP that labels extracellular vesicles including exosomes and microvesicles (EVs). The cell line is useful for the study of EV exchange between donor and acceptor cells and also for the study of tunnelling nanotubes (TnTs). The cell line is particularly useful for interaction-studies between myeloma and stroma-cells. |
| Research Area | Cell Type or Organelle Marker, Cell Structure and Motility, Fluorescent Cell Imaging, Structural Biology |
| Recommended Growing Conditions | Culture in RPMI-1640 with 5% heat inactivated fetal calf serum (FCS) added with 1 ng/ml IL-6 and 200 µg/ml G418 (Geneticin) at 37 °C in a humidified atmosphere containing 5% CO2. |
| Cellosaurus ID | CVCL_5209 |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
